Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer.

Holmes, Oliver Edwin; MacRae, Robert; Cook, Graham; Cross, Peter; Nair, Vimoj; Marginean, Horia; Pantarotto, Jason R

Holmes, Oliver Edwin; MacRae, Robert; Cook, Graham; Cross, Peter; Nair, Vimoj; Marginean, Horia; Pantarotto, Jason R.

Afiliación

Holmes OE; Division of Radiation Oncology, The University of Ottawa, Ottawa, Ontario, Canada.
MacRae R; Division of Radiation Oncology, The University of Ottawa, Ottawa, Ontario, Canada.
Cook G; Division of Radiation Oncology, The University of Ottawa, Ottawa, Ontario, Canada.
Cross P; Division of Radiation Oncology, The University of Ottawa, Ottawa, Ontario, Canada.
Nair V; Division of Radiation Oncology, The University of Ottawa, Ottawa, Ontario, Canada.
Marginean H; Department of Radiation Oncology, PEI Cancer Treatment Center, Charlottetown, PEI, Canada.
Pantarotto JR; The Ottawa Hospital Cancer Centre, Canada.

Clin Transl Radiat Oncol ; 5: 37-41, 2017 Aug.

Article en En | MEDLINE | ID: mdl-29594215

Palabras clave

Charlson Comorbidity Index; Medically inoperable; Non-small cell lung cancer; SABR

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Transl Radiat Oncol Año: 2017 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google